Apellis pharmaceutical products APLS it has outperformed the market over the last 5 years by 10.69% on an annual basis, producing an average annual return of 23.52%. Currently, Apellis Pharmaceuticals has a market capitalization of $7.02 billion.
Buy $1000 in APLS: If an investor had purchased $1000 worth of APLS stock 5 years ago, it would be worth it $3,017.45 today based on a price of $58.20 for APLS at the time of this writing.
Performance of Apellis Pharmaceuticals over the last 5 years
Finally: what is the purpose of all this? The key insight to take away from this article is to note how much of a difference compound returns can make in cash growth over a period of time.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade with confidence with insights and alerts from analyst ratings, free reports and breaking news on the stocks you care about.